[Cognitive impairments in patients with depression].
Kognitive Störungen bei Patienten mit Depression.
Diagnostics
Neuropsychology
Prevalence
Psychosocial functional level
Treatment
Journal
Der Nervenarzt
ISSN: 1433-0407
Titre abrégé: Nervenarzt
Pays: Germany
ID NLM: 0400773
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
accepted:
13
01
2021
pubmed:
2
3
2021
medline:
25
3
2021
entrez:
1
3
2021
Statut:
ppublish
Résumé
Cognitive impairments are frequent in patients suffering from major depressive disorders. They are among the first symptoms, often persist independently of improvement even after remission of the affective symptoms and are an important predictor of psychosocial functioning. In the clinical practice it is mandatory to ask about subjective complaints of the patient as well as to assess the cognitive abilities with the help of a standardized neuropsychological test battery. Cognitive remediation, selective serotonin reuptake inhibitors (SSRI) and vortioxetine as well as repetitive transcranial magnetic stimulation have proven their effectiveness as treatment options. Kognitive Störungen bei Patienten mit Depressionen sind häufig. Sie treten bereits zu Beginn der Erkrankung auf, persistieren auch nach Remission der affektiven Symptome und sind wichtiger Prädiktor für das psychosoziale Leistungsniveau. In der klinischen Praxis sollten sowohl die subjektiv wahrgenommenen Defizite erfragt, als auch die tatsächliche kognitive Leistungsfähigkeit mittels standardisierter Diagnostik erfasst werden. In der Behandlung haben sich neuropsychologische Verfahren der kognitiven Remediation, psychopharmakologisch SSRIs („selective serotonin reuptake inhibitors“) sowie Vortioxetin und neuromodulatorisch die repetitive transkranielle Magnetstimulation als wirksam erwiesen.
Autres résumés
Type: Publisher
(ger)
Kognitive Störungen bei Patienten mit Depressionen sind häufig. Sie treten bereits zu Beginn der Erkrankung auf, persistieren auch nach Remission der affektiven Symptome und sind wichtiger Prädiktor für das psychosoziale Leistungsniveau. In der klinischen Praxis sollten sowohl die subjektiv wahrgenommenen Defizite erfragt, als auch die tatsächliche kognitive Leistungsfähigkeit mittels standardisierter Diagnostik erfasst werden. In der Behandlung haben sich neuropsychologische Verfahren der kognitiven Remediation, psychopharmakologisch SSRIs („selective serotonin reuptake inhibitors“) sowie Vortioxetin und neuromodulatorisch die repetitive transkranielle Magnetstimulation als wirksam erwiesen.
Identifiants
pubmed: 33646323
doi: 10.1007/s00115-021-01074-4
pii: 10.1007/s00115-021-01074-4
doi:
Substances chimiques
Antidepressive Agents
0
Vortioxetine
3O2K1S3WQV
Types de publication
Journal Article
Langues
ger
Sous-ensembles de citation
IM
Pagination
277-288Références
Gualtieri CT, Morgan DW (2008) The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: an unaccounted source of variance in clinical trials. J Clin Psychiatry 69:1122–1130
doi: 10.4088/JCP.v69n0712
Story TJ, Potter GG, Attix DK et al (2008) Neurocognitive correlates of response to treatment in late-life depression. Am J Geriatr Psychiatry 16:752–759
doi: 10.1097/JGP.0b013e31817e739a
Mcintyre RS, Soczynska JZ, Woldeyohannes HO et al (2015) The impact of cognitive impairment on perceived workforce performance: results from the international mood disorders collaborative project. Compr Psychiatry 56:279–282
doi: 10.1016/j.comppsych.2014.08.051
Lee RS, Hermens DF, Porter MA et al (2012) A meta-analysis of cognitive deficits in first-episode major depressive disorder. J Affect Disord 140:113–124
doi: 10.1016/j.jad.2011.10.023
Rock PL, Roiser JP, Riedel WJ et al (2014) Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med 44:2029–2040
doi: 10.1017/S0033291713002535
Snyder HR (2013) Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol Bull 139:81–132
doi: 10.1037/a0028727
Bora E, Harrison BJ, Yucel M et al (2013) Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychol Med 43:2017–2026
doi: 10.1017/S0033291712002085
Schwert C, Stohrer M, Aschenbrenner S et al (2019) Neurocognitive profile of outpatients with unipolar depressive disorders. J Clin Exp Neuropsychol 41:913–924
doi: 10.1080/13803395.2019.1634180
Buist-Bouwman MA, Ormel J, de Graaf R et al (2008) Mediators of the association between depression and role functioning. Acta Psychiatr Scand 118:451–458
doi: 10.1111/j.1600-0447.2008.01285.x
Westheide J, Quednow BB, Kuhn KU et al (2008) Executive performance of depressed suicide attempters: the role of suicidal ideation. Eur Arch Psychiatry Clin Neurosci 258:414–421
doi: 10.1007/s00406-008-0811-1
Cambridge OR, Knight MJ, Mills N et al (2018) The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: a systematic review. Psychiatry Res 269:157–171
doi: 10.1016/j.psychres.2018.08.033
Mclennan SN, Mathias JL (2010) The depression-executive dysfunction (DED) syndrome and response to antidepressants: a meta-analytic review. Int J Geriatr Psychiatry 25:933–944
doi: 10.1002/gps.2431
Beblo T, Kunz M, Lautenbacher S et al (2011) Wiener Testsystem: Fragebogen zur geistigen Leistungsfähigkeit. Schuhfried, Mödling
Ott CV, Bjertrup AJ, Jensen JH et al (2016) Screening for cognitive dysfunction in unipolar depression: validation and evaluation of objective and subjective tools. J Affect Disord 190:607–615
doi: 10.1016/j.jad.2015.10.059
Aschenbrenner S, Kaiser S, Pfüller U et al (2012) Wiener Testsystem: Testset Kognitive Basistestung (CogBat). Schuhfried, Mödling
Weber B, Fritze J, Schneider B et al (2002) Bias in computerized neuropsychological assessment of depressive disorders caused by computer attitude. Acta Psychiatr Scand 105:126–130
doi: 10.1034/j.1600-0447.2002.01100.x
Hagen BI, Lau B, Joormann J et al (2020) Goal management training as a cognitive remediation intervention in depression: a randomized controlled trial. J Affect Disord 275:268–277
doi: 10.1016/j.jad.2020.07.015
Grynszpan O, Perbal S, Pelissolo A et al (2011) Efficacy and specificity of computer-assisted cognitive remediation in schizophrenia: a meta-analytical study. Psychol Med 41:163–173
doi: 10.1017/S0033291710000607
Motter JN, Pimontel MA, Rindskopf D et al (2016) Computerized cognitive training and functional recovery in major depressive disorder: a meta-analysis. J Affect Disord 189:184–191
doi: 10.1016/j.jad.2015.09.022
Trapp W, Engel S, Hajak G et al (2016) Cognitive remediation for depressed inpatients: results of a pilot randomized controlled trial. Aust N Z J Psychiatry 50:46–55
doi: 10.1177/0004867415622271
Listunova L, Kienzle J, Bartolovic M et al (2020) Cognitive remediation therapy for partially remitted unipolar depression: a single-blind randomized controlled trial. J Affect Disord 276:316–326
doi: 10.1016/j.jad.2020.07.008
Prado CE, Watt S, Crowe SF (2018) A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples. Neuropsychol Rev 28:32–72
doi: 10.1007/s11065-018-9369-5
McIntyre RS, Harrison J, Loft H et al (2016) The effects of vortioxetine on cognitive function in patients with major depressive disorder: a meta-analysis of three randomized controlled trials. Int J Neuropsychopharmacol 19(10):pyw55. https://doi.org/10.1093/ijnp/pyw055
doi: 10.1093/ijnp/pyw055
pubmed: 27312740
pmcid: 5091829
Spring B, Gelenberg AJ, Garvin R et al (1992) Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients. Psychopharmacology (Berl) 108:327–332
doi: 10.1007/BF02245119
Razza LB, Palumbo P, Moffa AH et al (2020) A systematic review and meta-analysis on the effects of transcranial direct current stimulation in depressive episodes. Depress Anxiety 37:594–608
doi: 10.1002/da.23004
Lefaucheur JP, Aleman A, Baeken C et al (2020) Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014–2018). Clin Neurophysiol 131:474–528
doi: 10.1016/j.clinph.2019.11.002
Martin DM, Moffa A, Nikolin S et al (2018) Cognitive effects of transcranial direct current stimulation treatment in patients with major depressive disorder: an individual patient data meta-analysis of randomised, sham-controlled trials. Neurosci Biobehav Rev 90:137–145
doi: 10.1016/j.neubiorev.2018.04.008
Martin DM, Mcclintock SM, Forster JJ et al (2017) Cognitive enhancing effects of rTMS administered to the prefrontal cortex in patients with depression: a systematic review and meta-analysis of individual task effects. Depress Anxiety 34:1029–1039
doi: 10.1002/da.22658
Semkovska M, McLoughlin DM (2010) Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry 68:568–577
doi: 10.1016/j.biopsych.2010.06.009
Porter RJ, Baune BT, Morris G et al (2020) Cognitive side-effects of electroconvulsive therapy: what are they, how to monitor them and what to tell patients. BJPsych open 6:e40
doi: 10.1192/bjo.2020.17